Telehealth
The layoffs make up about 6% of the virtual care giant's non-clinician workforce.
Drug development platform Quris raised another $9 million, and PharmStars is accepting applications for its accelerator cohort focused on women's health and health equity.
![[Left-Right] Travis Seet, CFO, and Dr Chin Pak Lin, CEO, Asian Healthcare Specialists; Lim Wai Mun, CEO and founder, and Edwin Basuki, CFO, Doctor Anywhere Credit: Doctor Anywhere](/sites/mhn/files/styles/230x130/public/2025-07/Photo_Doctor%2520Anywhere%2520acquires%2520Singapore-listed%2520Asian%2520Healthcare%2520Specialists%252C%2520secures%2520additional%2520US%252438.8%2520million%2520funding.jpg?itok=BMyCZa_X)
The company seeks to meet the rising demand for specialised care across Southeast Asia.
MediOrbis will incorporate Kahun's AI tool into its platform to provide clinical insights to healthcare providers based on patients’ intake information.
Telemedicine use has declined since the height of the COVID-19 pandemic. Providers can rethink how they use telehealth to get the most out of the modality and improve care.
Sanjula Jain, senior vice president of market strategy and chief research officer at Trilliant Health, discusses the future of virtual care and how emerging retail players will affect the industry.
It is offering free two-week access to the FibriCheck feature on its app for the first 100,000 users.
Medical waste-management firm Stericycle sold the business to Carenet for approximately $45 million in cash.
According to the Israeli news site Calcalist, Amwell is in talks to purchase Talkspace for around $1.50 per share.
SPONSORED
|
01:00 am |
November 28, 2022
|
01:00 am |
November 28, 2022
New research finds using a smartphone app more than doubles detection and treatment rates in older people